Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-17-337427
Filing Date
2017-11-08
Accepted
2017-11-08 17:22:03
Documents
12

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS d477966d424b4.htm 424B4 1957229
2 GRAPHIC g477966g03p82.jpg GRAPHIC 70215
3 GRAPHIC g477966g11k42.jpg GRAPHIC 66188
4 GRAPHIC g477966g15h94.jpg GRAPHIC 43981
5 GRAPHIC g477966g16r20.jpg GRAPHIC 46135
6 GRAPHIC g477966g29w63.jpg GRAPHIC 97351
7 GRAPHIC g477966g33u65.jpg GRAPHIC 28461
8 GRAPHIC g477966g34i59.jpg GRAPHIC 48162
9 GRAPHIC g477966g49v54.jpg GRAPHIC 53429
10 GRAPHIC g477966g56y70.jpg GRAPHIC 22641
11 GRAPHIC g477966g63h88.jpg GRAPHIC 42480
12 GRAPHIC g477966g69z53.jpg GRAPHIC 108773
  Complete submission text file 0001193125-17-337427.txt   2821498
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-220962 | Film No.: 171187569
SIC: 2834 Pharmaceutical Preparations